• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿片类药物、疼痛管理与法律。

Opioids, pain management and the law.

机构信息

Division of Pain Medicine, Department of Anesthesiology, University of California, Davis School of Medicine, California 95817, USA.

出版信息

Curr Opin Anaesthesiol. 2012 Oct;25(5):566-71. doi: 10.1097/ACO.0b013e328357a24a.

DOI:10.1097/ACO.0b013e328357a24a
PMID:22914352
Abstract

PURPOSE OF REVIEW

Approximately 100 million people suffer from chronic pain in the USA. Opioid medications are commonly prescribed to treat pain, but are becoming the most widely misused controlled substance nationally. Physicians who treat patients with chronic pain must be cognizant of the federal and state policies that govern the distribution of opioid medications as well as the current standards of medical practice for opioid prescribing.

RECENT FINDINGS

The laws and policies regarding the standard medical practice for opioid prescribing are constantly subject to revision. The National Drug Control Policy announced its plan to fight prescription drug abuse in 2011 and unveiled the Risk Evaluation and Management Strategy initiative. Currently there is a Risk Evaluation and Management Strategy for Transmucosal Immediate-Release Fentanyl. Other resources, such as state-run prescription drug monitoring programs, are also available to many physicians. The level of participation in these programs by physicians and pharmacists varies by state, and funding for continuation of these programs is an ongoing issue.

SUMMARY

The problems of undertreated pain and the epidemic of prescription drug abuse have coincided, creating a need for medical and social policy that protects society and access to appropriate care for those in pain. Federal and state laws are in evolution, and clinicians must remain aware of these changes as well as the issues behind them that will impact safe and appropriate care of patients in pain.

摘要

目的综述:美国约有 1 亿人患有慢性疼痛。阿片类药物通常被用于治疗疼痛,但已成为全国范围内使用最广泛的滥用受控物质。治疗慢性疼痛患者的医生必须了解管理阿片类药物分配的联邦和州政策以及阿片类药物处方的当前医学实践标准。

最新发现:关于阿片类药物处方标准医学实践的法律和政策不断修订。国家毒品管制政策于 2011 年宣布了打击处方药物滥用的计划,并公布了风险评估和管理策略倡议。目前,有一项 Transmucosal Immediate-Release Fentanyl 的风险评估和管理策略。许多医生还可以使用其他资源,例如州立处方药物监测计划。医生和药剂师对这些计划的参与程度因州而异,这些计划的持续资金是一个持续存在的问题。

总结:治疗不足的疼痛问题和处方药物滥用的流行同时出现,这需要医疗和社会政策来保护社会并为疼痛患者提供适当的护理。联邦和州法律正在不断演变,临床医生必须了解这些变化以及背后的问题,这些问题将影响疼痛患者的安全和适当护理。

相似文献

1
Opioids, pain management and the law.阿片类药物、疼痛管理与法律。
Curr Opin Anaesthesiol. 2012 Oct;25(5):566-71. doi: 10.1097/ACO.0b013e328357a24a.
2
American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part I--evidence assessment.美国介入性疼痛医师学会(ASIPP)慢性非癌痛阿片类药物处方责任指南:第一部分——证据评估。
Pain Physician. 2012 Jul;15(3 Suppl):S1-65.
3
Managing co-occurring substance use and pain disorders.管理共病物质使用和疼痛障碍。
Psychiatr Clin North Am. 2012 Jun;35(2):393-409. doi: 10.1016/j.psc.2012.03.006. Epub 2012 May 5.
4
Prescription opioid abuse in chronic pain: a review of opioid abuse predictors and strategies to curb opioid abuse.慢性疼痛患者处方阿片类药物滥用:阿片类药物滥用预测因子及抑制阿片类药物滥用策略的综述。
Pain Physician. 2012 Jul;15(3 Suppl):ES67-92.
5
Opioid epidemic in the United States.美国的阿片类药物泛滥问题。
Pain Physician. 2012 Jul;15(3 Suppl):ES9-38.
6
National drug control policy and prescription drug abuse: facts and fallacies.国家药物管制政策与处方药滥用:事实与谬误
Pain Physician. 2007 May;10(3):399-424.
7
Evolution of opioid risk management and review of the classwide REMS for extended-release/long-acting opioids.阿片类药物风险管理的演变及对延长释放/长效阿片类药物的全类风险评估与管理计划的回顾。
Phys Sportsmed. 2012 Nov;40(4):12-20. doi: 10.3810/psm.2012.11.1975.
8
State medical board members' beliefs about pain, addiction, and diversion and abuse: a changing regulatory environment.州医学委员会成员对疼痛、成瘾以及药物转移和滥用的看法:不断变化的监管环境。
J Pain. 2007 Sep;8(9):682-91. doi: 10.1016/j.jpain.2007.05.012. Epub 2007 Jul 12.
9
Risk assessment and counseling behaviors of healthcare professionals managing patients with chronic pain: a national multifaceted assessment of physicians, pharmacists, and their patients.管理慢性疼痛患者的医疗保健专业人员的风险评估与咨询行为:对医生、药剂师及其患者的全国多方面评估。
J Opioid Manag. 2012 Sep-Oct;8(5):273-84. doi: 10.5055/jom.2012.0127.
10
Rational use of opioids for management of chronic nonterminal pain.慢性非终末期疼痛的阿片类药物合理使用。
Am Fam Physician. 2012 Aug 1;86(3):252-8.

引用本文的文献

1
Advances in the use of local anesthetic extended-release systems in pain management.局部麻醉药控释系统在疼痛管理中的应用进展。
Drug Deliv. 2024 Dec;31(1):2296349. doi: 10.1080/10717544.2023.2296349. Epub 2023 Dec 21.
2
The Use of Conditioning Open-Label Placebo in Opioid Dose Reduction: A Case Report and Literature Review.条件性开放标签安慰剂在阿片类药物剂量减少中的应用:病例报告及文献综述
Front Pain Res (Lausanne). 2021 Jul 12;2:697475. doi: 10.3389/fpain.2021.697475. eCollection 2021.
3
Kratom Use Within the Context of the Evolving Opioid Crisis and the COVID-19 Pandemic in the United States.
在美国不断演变的阿片类药物危机和新冠疫情背景下的 kratom 使用情况
Front Pharmacol. 2021 Aug 26;12:729220. doi: 10.3389/fphar.2021.729220. eCollection 2021.
4
Government Legislation in Response to the Opioid Epidemic.政府应对阿片类药物泛滥的立法。
Curr Pain Headache Rep. 2019 May 1;23(6):40. doi: 10.1007/s11916-019-0781-1.
5
Targeting practitioners: A review of guidelines, training, and policy in pain management.针对从业者:疼痛管理指南、培训及政策综述
Drug Alcohol Depend. 2017 Apr 1;173 Suppl 1(Suppl 1):S22-S30. doi: 10.1016/j.drugalcdep.2016.08.641.